The global neurostimulation devices market size is calculated at USD 13.92 billion in 2025 and is forecasted to reach around USD 37.30 billion by 2034, accelerating at a CAGR of 11.60% from 2025 to 2034. The North America market size surpassed USD 7.72 billion in 2024 and is expanding at a CAGR of 11.62% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Neurostimulation Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Neurostimulation Devices Market, by Technology
8.1.1. Aneurysm coiling & embolization devices
8.1.1.1. Market Revenue and Forecast
8.1.2. Cerebral balloon angioplasty & Stenting systems
8.1.2.1. Market Revenue and Forecast
8.1.3. Support devices
8.1.3.1. Market Revenue and Forecast
8.1.4. Neurothrombectomy devices
8.1.4.1. Market Revenue and Forecast
9.1. Neurostimulation Devices Market, by Disease Pathology
9.1.1. Ischemic Strokes
9.1.1.1. Market Revenue and Forecast
9.1.2. Cerebral Aneuryms
9.1.2.1. Market Revenue and Forecast
9.1.3. Carotid Artery Stenosis
9.1.3.1. Market Revenue and Forecast
9.1.4. Arteriovenous Malformations and Fistulas
9.1.4.1. Market Revenue and Forecast
9.1.5. Other Diseases
9.1.5.1. Market Revenue and Forecast
10.1. Neurostimulation Devices Market, by Product
10.1.1. Spinal Cord Stimulator
10.1.1.1. Market Revenue and Forecast
10.1.2. Deep Brain Stimulator
10.1.2.1. Market Revenue and Forecast
10.1.3. Sacral Nerve Stimulator
10.1.3.1. Market Revenue and Forecast
10.1.4. Vagus Nerve Stimulator
10.1.4.1. Market Revenue and Forecast
10.1.5. Gastric Electric Stimulator
10.1.5.1. Market Revenue and Forecast
11.1. Neurostimulation Devices Market, by Application
11.1.1. Pain Management
11.1.1.1. Market Revenue and Forecast
11.1.2. Epilepsy
11.1.2.1. Market Revenue and Forecast
11.1.3. Essential Tremor
11.1.3.1. Market Revenue and Forecast
11.1.4. Urinary and Fecal Incontinence
11.1.4.1. Market Revenue and Forecast
11.1.5. Depression
11.1.5.1. Market Revenue and Forecast
11.1.6. Dystonia
11.1.6.1. Market Revenue and Forecast
11.1.7. Gastroparesis
11.1.7.1. Market Revenue and Forecast
11.1.8. Parkinson’s Disease
11.1.8.1. Market Revenue and Forecast
11.1.9. Others
11.1.9.1. Market Revenue and Forecast
12.1. Neurostimulation Devices Market, by End Users
12.1.1. Hospitals & Surgical Centers
12.1.1.1. Market Revenue and Forecast
12.1.2. Ambulatory Care Centers
12.1.2.1. Market Revenue and Forecast
12.1.3. Research Laboratories & Academic Institutes
12.1.3.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Technology
13.1.2. Market Revenue and Forecast, by Disease Pathology
13.1.3. Market Revenue and Forecast, by Product
13.1.4. Market Revenue and Forecast, by Application
13.1.5. Market Revenue and Forecast, by End Users
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Technology
13.1.6.2. Market Revenue and Forecast, by Disease Pathology
13.1.6.3. Market Revenue and Forecast, by Product
13.1.6.4. Market Revenue and Forecast, by Application
13.1.7. Market Revenue and Forecast, by End Users
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Technology
13.1.8.2. Market Revenue and Forecast, by Disease Pathology
13.1.8.3. Market Revenue and Forecast, by Product
13.1.8.4. Market Revenue and Forecast, by Application
13.1.8.5. Market Revenue and Forecast, by End Users
13.2. Europe
13.2.1. Market Revenue and Forecast, by Technology
13.2.2. Market Revenue and Forecast, by Disease Pathology
13.2.3. Market Revenue and Forecast, by Product
13.2.4. Market Revenue and Forecast, by Application
13.2.5. Market Revenue and Forecast, by End Users
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Technology
13.2.6.2. Market Revenue and Forecast, by Disease Pathology
13.2.6.3. Market Revenue and Forecast, by Product
13.2.7. Market Revenue and Forecast, by Application
13.2.8. Market Revenue and Forecast, by End Users
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Technology
13.2.9.2. Market Revenue and Forecast, by Disease Pathology
13.2.9.3. Market Revenue and Forecast, by Product
13.2.10. Market Revenue and Forecast, by Application
13.2.11. Market Revenue and Forecast, by End Users
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Technology
13.2.12.2. Market Revenue and Forecast, by Disease Pathology
13.2.12.3. Market Revenue and Forecast, by Product
13.2.12.4. Market Revenue and Forecast, by Application
13.2.13. Market Revenue and Forecast, by End Users
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Technology
13.2.14.2. Market Revenue and Forecast, by Disease Pathology
13.2.14.3. Market Revenue and Forecast, by Product
13.2.14.4. Market Revenue and Forecast, by Application
13.2.15. Market Revenue and Forecast, by End Users
13.3. APAC
13.3.1. Market Revenue and Forecast, by Technology
13.3.2. Market Revenue and Forecast, by Disease Pathology
13.3.3. Market Revenue and Forecast, by Product
13.3.4. Market Revenue and Forecast, by Application
13.3.5. Market Revenue and Forecast, by End Users
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Technology
13.3.6.2. Market Revenue and Forecast, by Disease Pathology
13.3.6.3. Market Revenue and Forecast, by Product
13.3.6.4. Market Revenue and Forecast, by Application
13.3.7. Market Revenue and Forecast, by End Users
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Technology
13.3.8.2. Market Revenue and Forecast, by Disease Pathology
13.3.8.3. Market Revenue and Forecast, by Product
13.3.8.4. Market Revenue and Forecast, by Application
13.3.9. Market Revenue and Forecast, by End Users
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Technology
13.3.10.2. Market Revenue and Forecast, by Disease Pathology
13.3.10.3. Market Revenue and Forecast, by Product
13.3.10.4. Market Revenue and Forecast, by Application
13.3.10.5. Market Revenue and Forecast, by End Users
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Technology
13.3.11.2. Market Revenue and Forecast, by Disease Pathology
13.3.11.3. Market Revenue and Forecast, by Product
13.3.11.4. Market Revenue and Forecast, by Application
13.3.11.5. Market Revenue and Forecast, by End Users
13.4. MEA
13.4.1. Market Revenue and Forecast, by Technology
13.4.2. Market Revenue and Forecast, by Disease Pathology
13.4.3. Market Revenue and Forecast, by Product
13.4.4. Market Revenue and Forecast, by Application
13.4.5. Market Revenue and Forecast, by End Users
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Technology
13.4.6.2. Market Revenue and Forecast, by Disease Pathology
13.4.6.3. Market Revenue and Forecast, by Product
13.4.6.4. Market Revenue and Forecast, by Application
13.4.7. Market Revenue and Forecast, by End Users
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Technology
13.4.8.2. Market Revenue and Forecast, by Disease Pathology
13.4.8.3. Market Revenue and Forecast, by Product
13.4.8.4. Market Revenue and Forecast, by Application
13.4.9. Market Revenue and Forecast, by End Users
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Technology
13.4.10.2. Market Revenue and Forecast, by Disease Pathology
13.4.10.3. Market Revenue and Forecast, by Product
13.4.10.4. Market Revenue and Forecast, by Application
13.4.10.5. Market Revenue and Forecast, by End Users
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Technology
13.4.11.2. Market Revenue and Forecast, by Disease Pathology
13.4.11.3. Market Revenue and Forecast, by Product
13.4.11.4. Market Revenue and Forecast, by Application
13.4.11.5. Market Revenue and Forecast, by End Users
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Technology
13.5.2. Market Revenue and Forecast, by Disease Pathology
13.5.3. Market Revenue and Forecast, by Product
13.5.4. Market Revenue and Forecast, by Application
13.5.5. Market Revenue and Forecast, by End Users
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Technology
13.5.6.2. Market Revenue and Forecast, by Disease Pathology
13.5.6.3. Market Revenue and Forecast, by Product
13.5.6.4. Market Revenue and Forecast, by Application
13.5.7. Market Revenue and Forecast, by End Users
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Technology
13.5.8.2. Market Revenue and Forecast, by Disease Pathology
13.5.8.3. Market Revenue and Forecast, by Product
13.5.8.4. Market Revenue and Forecast, by Application
13.5.8.5. Market Revenue and Forecast, by End Users
14.1. Medtronic PLC
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Cyberonics
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Boston Scientific Corp.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. St. Jude Medical, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Nevro Corp.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. MicroPort Scientific Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Kaneka Corp
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Integer Holdings Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. BALT
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Perflow Medical
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample